Literature DB >> 32699276

Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China.

Yuanwei Liu1, Haiyue Li1, Keqing Cao1, Jianfeng Liu1, Yao Sun1, Jiamin Wu1, Zichao Xiong1, Fanglin Niu1, Jing Li1, Tianbo Jin2,3.   

Abstract

Drug gene polymorphisms are strongly associated with disease. Previous studies have shown that the frequency of drug genes varies in different populations. At present, there are no reports about the polymorphism of the drug genome in the Zhuang population in southern China. This study conducted a pharmacogenomics study on the Zhuang population in southern China. Therefore, we conducted genotyping on 105 Zhuang samples, and compared the genotyping results with those of other 11 ethnic groups after statistical analysis. Our results show that, compared with the 11 populations in the HapMap data set, the differences between the CYP2E1 rs2070676 and CYP2D6 rs1065852 of the Zhuang nationality are the largest. This study fills in the blank of the drug genome information of the Zhuang nationality in southern China. The two sites of Rs2070676 (CYP2E1) and rs1065852 (CYP2D6) provide a reliable basis for the prediction of the efficacy of certain drugs. Its main purpose is to provide theoretical basis for safe drug use in the Zhuang region of southern China.

Entities:  

Year:  2020        PMID: 32699276     DOI: 10.1038/s41397-020-0177-y

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  2 in total

1.  Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.

Authors:  Yongjun He; Hua Yang; Tingting Geng; Tian Feng; Dongya Yuan; Longli Kang; Manling Luo; Tianbo Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  Pharmacogenomics: marshalling the human genome to individualise drug therapy.

Authors:  W E Evans
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

  2 in total
  2 in total

1.  Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.

Authors:  Shuangyu Yang; Xia Dou; Zhen Wang; Wenjie Zhang; Kefan Ding; Wenting Meng; Haiyue Li; Jianfeng Liu; Yuanwei Liu; Tianbo Jin
Journal:  Mol Genet Genomics       Date:  2022-02-11       Impact factor: 3.291

2.  Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China.

Authors:  Yuliang Wang; Linna Peng; Hongyan Lu; Zhanhao Zhang; Shishi Xing; Dandan Li; Chunjuan He; Tianbo Jin; Li Wang
Journal:  Pharmgenomics Pers Med       Date:  2021-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.